Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Adjuvant ovarian function suppression in premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2–negative early breast cancer: a multi-center retrospective study

Fig. 6

Disease-free survival difference between underwent OFS or non-OFS among premenopausal patients with non-chemotherapy cohort. (A) Disease-free survival difference between underwent OFS or non-OFS among patients with CR-score>1.42. (B) Disease-free survival difference between underwent OFS or non-OFS among patients with CR-score ≤ 1.42. OFS, ovarian function suppression; CR-score, composite recurrence risk score

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us